The Economics of Antimicrobial Stewardship: The Current State of the Art and Applying the Business Case Model

Strategies for Reduction in Duration of Antibiotic Use in Hospitalized Patients

(2011) Y. Hayashi et al.   CLINICAL INFECTIOUS DISEASES

Deriving Measures of Intensive Care Unit Antimicrobial Use from Computerized Pharmacy Data: Methods, Validation, and Overcoming Barriers

(2011) David N. Schwartz et al.   INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY

Antimicrobial stewardship for inpatient facilities

(2011) Christopher A. Ohl et al.   Journal of Hospital Medicine

Clinical and Economic Outcomes Attributable to Health Care–Associated Sepsis and Pneumonia

(2010) Michael R. Eber   ARCHIVES OF INTERNAL MEDICINE

An Antimicrobial Stewardship Program’s Impact with Rapid Polymerase Chain Reaction Methicillin‐ResistantStaphylococcus aureus/S. aureusBlood Culture Test in Patients withS. aureusBacteremia

(2010) Karri A. Bauer et al.   CLINICAL INFECTIOUS DISEASES

Understanding cost-effectiveness

(2010) M.D. Zilberberg et al.   CLINICAL MICROBIOLOGY AND INFECTION

Cost-effectiveness analysis of an antimicrobial stewardship team on bloodstream infections: a probabilistic analysis

(2009) M. H. Scheetz et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Economic burden of healthcare-associated infections: an American perspective

(2009) Patricia W Stone   Expert Review of Pharmacoeconomics & Outcomes Research